KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Income from Continuing Operations (2016 - 2025)

Pacific Biosciences Of California (PACB) has 16 years of Income from Continuing Operations data on record, last reported at 40371000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 1802.7% year-over-year to 40371000.0; the TTM value through Dec 2025 reached 546376000.0, down 76.34%, while the annual FY2025 figure was 546376000.0, 76.34% down from the prior year.
  • Income from Continuing Operations reached 40371000.0 in Q4 2025 per PACB's latest filing, down from 38000000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 16542000.0 in Q3 2021 and bottomed at 426075000.0 in Q1 2025.
  • Average Income from Continuing Operations over 5 years is 80332950.0, with a median of 69581500.0 recorded in 2021.
  • Peak YoY movement for Income from Continuing Operations: soared 169.77% in 2021, then plummeted 1802.7% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 69330000.0 in 2021, then fell by 21.71% to 84384000.0 in 2022, then increased by 2.8% to 82018000.0 in 2023, then surged by 102.89% to 2371000.0 in 2024, then tumbled by 1802.7% to 40371000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 40371000.0 in Q4 2025, 38000000.0 in Q3 2025, and 41930000.0 in Q2 2025.